Comparison of Ultrasound-Guided Infraclavicular Block and Ultrasound-Guided Axillary Block
1 other identifier
interventional
224
1 country
2
Brief Summary
The purpose of this study is to compare the rate of complete sensory block at 30 minutes following ultrasound-guided single injection infraclavicular block and ultrasound-guided double injection axillary block. The investigators research hypothesis is that both blocks will show comparable rates of complete sensory block at 30 minutes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2012
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 3, 2013
CompletedFirst Posted
Study publicly available on registry
January 4, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedResults Posted
Study results publicly available
August 4, 2017
CompletedAugust 4, 2017
April 1, 2017
5 months
January 3, 2013
March 28, 2014
April 25, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Patients With Complete Sensory Block
Complete sensory block is defined by anesthesia to cold sensation in the ulnar, radial, median and musculocutaneous nerves territories.
30 minutes after block completion
Secondary Outcomes (11)
Number of Patients With Complete Motor Blocks
30 minutes after block completion
Time to Complete Sensory Block.
5, 10, 15, 20, 25 and 30 minutes after block completion
Time to Complete Motor Block
5, 10, 15, 20, 25 and 30 minutes after block completion
Surgical Block Success Rate
End of surgery
Performance Time of the Nerve Block
During the performance of the block
- +6 more secondary outcomes
Study Arms (2)
Ultrasound-guided infraclavicular block
ACTIVE COMPARATORUltrasound-guided single injection infraclavicular block
Ultrasound-guided axillary block
ACTIVE COMPARATORUltrasound-guided double injection axillary block
Interventions
Ultrasound-guided single injection infraclavicular block: using an in-plane technique, 30 mL of mepivacaine 1.5% is injected at the posterior aspect of the artery.
Ultrasound-guided double injection axillary block: using an in-plane technique, 25 mL of mepivacaine 1.5% is injected postero-medial to the artery. During needle withdrawal, 5 mL of the same solution is injected close to the musculocutaneous nerve.
Eligibility Criteria
You may qualify if:
- years or older
- American Society of Anesthesiologists Class 1 to 3
- Undergoing a surgery at the elbow, forearm, wrist or hand under regional anesthesia
You may not qualify if:
- Age less than 18 years
- Body mass index more than 40 kg/m2
- Weight less than 45 kg
- Patient refusal
- Contraindication to regional anesthesia (coagulopathy, local infection at the puncture site, systemic infection)
- Previous neurological deficit in the operated arm
- Severe renal or hepatic failure
- Prior surgery in the axillary or infraclavicular area
- Pregnancy or breast-feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hôpital de l'Enfant-Jésus
Québec, G1J 1Z4, Canada
Hôpital de Saint-Sacrement
Québec, G1S 4L8, Canada
Related Publications (1)
Boivin A, Nadeau MJ, Dion N, Levesque S, Nicole PC, Turgeon AF. Ultrasound-Guided Single-Injection Infraclavicular Block Versus Ultrasound-Guided Double-Injection Axillary Block: A Noninferiority Randomized Controlled Trial. Anesth Analg. 2016 Jan;122(1):273-8. doi: 10.1213/ANE.0000000000001017.
PMID: 26516803DERIVED
Results Point of Contact
- Title
- Dre Marie-Josée Nadeau
- Organization
- CHU de Québec, Département d'Anesthésie-Réanimation de l'Hôpital de l'Enfant-Jésus
Study Officials
- PRINCIPAL INVESTIGATOR
Ariane Boivin, MD
CHU de Québec
- PRINCIPAL INVESTIGATOR
Marie-Josée Nadeau, MD
CHU de Québec
- PRINCIPAL INVESTIGATOR
Nicolas Dion, MD
CHU de Québec
- PRINCIPAL INVESTIGATOR
Simon Lévesque, MD
CHU de Québec
- PRINCIPAL INVESTIGATOR
Pierre C. Nicole, MD
CHU de Québec
- PRINCIPAL INVESTIGATOR
Alexis F. Turgeon, MD, Msc
CHU de Québec
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 3, 2013
First Posted
January 4, 2013
Study Start
September 1, 2012
Primary Completion
February 1, 2013
Study Completion
March 1, 2013
Last Updated
August 4, 2017
Results First Posted
August 4, 2017
Record last verified: 2017-04